ABC | Volume 113, Nº1, July 2019

Statement Statement on Antiplatelet Agents and Anticoagulants in Cardiology – 2019 Arq Bras Cardiol. 2019; 113(1):111-134 Brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia. Arq Bras Cardiol. 2013;101(3 Supl.3):1-93. 108. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46(9):1768-76. 109. Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med. 2004;164(9):950-6. 110. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38(3):613-23. 111. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47(2):440-5. 112. Di Tullio MR. Patent foramen ovale: echocardiographic detection and clinical relevance in stroke. J Am Soc Echocardiogr. 2010;23(2):144-55. 113. Penther P. [Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies]. Arch Mal Coeur Vaiss. 1994;87(1):15-21. 114. Schroeckenstein RF, Wasenda GJ, Edwards JE. Valvular competent patent foramen ovale in adults. Minn Med. 1972;55(1):11-3. 115. Hagen PT, ScholzDG, EdwardsWD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20. 116. Rigatelli G, Ronco F. Patent foramen ovale: a comprehensive review for pulmonologists. Curr Opin PulmMed. 2010;16(5):442-7. 117. Billinger M, Zbinden R, Mordasini R, Windecker S, Schwerzmann M, Meier B, et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart. 2011;97(23):1932-7. 118. TortiSR,BillingerM,SchwerzmannM,VogelR,ZbindenR,WindeckerS,et al.Riskofdecompressionillnessamong230diversinrelationtothepresence and size of patent foramen ovale. Eur Heart J. 2004;25(12):1014-20. 119. Wohrle J, Kochs M, Hombach V, Merkle N. Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale. JACC Cardiovasc Imaging. 2010;3(8):833-9. 120. Neisius U, Northridge DB, Cruden NL, Denvir MA. Myocardial infarction associated with patent foramen ovale and paradoxical embolism: case series. Int J Cardiol. 2015 Feb 1;180:34-7. 121. Lau EM, Yee BJ, Grunstein RR, Celermajer DS. Patent foramen ovale and obstructive sleep apnea: a new association? Sleep Med Rev. 2010;14(6):391-5. 122. Sevgi EB, Erdener SE, Demirci M, Topcuoglu MA, Dalkara T. Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine. J AmHeart Assoc. 2012;1(6):e001735. 123. Rundek T, ElkindMS, Di TullioMR, Carrera E, Jin Z, Sacco RL, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern ManhattanStudy (NOMAS).Circulation.2008;118(14):1419-24.Erratum in: Circulation. 2008;118(18):e682. 124. Lip PZ, Lip GY. Patent foramen ovale and migraine attacks: a systematic review. Am J Med. 2014;127(5):411-20. 125. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397-404. Erratum in: Circulation. 2009;120(9):e71-2. 126. Cohnheim JF. Vorlesungen Uber Allgemenie Pathologie. 2nd ed. Berlin: August Hirschwald; 1987. 127. Rundek T. PFO in stroke: a direct association or coincidence? Eur J Neurol. 2008:15(9):887-8. 128. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55(8):1172-9. 129. Handke M, Harloff A, Olschewski M. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357(22):2262-8. 130. Negrão EM, Brandi IV, Nunes SV, Távaro DG, Nakayama M, Beraldo PS. Patent foramen ovale and ischemic stroke in young people: statistical association or causal relation?. Arq Bras Cardiol. 2007;88(5):514-20. 131. Katsanos AH, Spence JD, Bogiatzi C, Parissis J, Giannopoulos S, Frogoudaki A, et al. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis. Stroke. 2014;45(11):3352-9. 132. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49(7):797-802. 133. Di Tullio MR, Jin Z, Russo C, Elkind MS, Rundek T, Yoshita M, et al. Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol. 2013;62(1):35-41. 134. Homma S, M Steven, Rundej T, Yee-Ping S, Franke J, Davidson K, et al. Patent foramen ovale. Nature Reviews Disease Primer. 2016 Jan;2:15087. 135. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619-25. 136. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med. 2000;109(6):456-62. 137. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke. 1994;25(3):582-6. 138. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31(10):2407-13. 139. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C, Price TR. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. AmHeart J. 1996;131(1):158-61. 140. Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke. 1994;25(4):782-6. 141. Rigatelli G, Dell’avvocata F, BraggionG, GiordanM, ChinagliaM, Cardaioli P. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheter Cardiovasc Interv. 2008;72(7):973-6. 142. Serena J, Marti-Fàbregas J, Santamarina E, Rodríguez JJ, Perez-Ayuso MJ, Masjuan J, et al. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke. 2008;39(12):3131-6. 143. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24):1740-6. 144. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105(22):2625-31. 145. PettyGW,KhandheriaBK,Meissner I,Whisnant JP,RoccaWA,Christianson TJ, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81(5):602-8. 146. Meschia J, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension.Guidelines fortheprimarypreventionofstroke:astatement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2014; 45(12):3754-832. 147. Shariat A, Yaghoubi E, Farazdaghi M, Aghasadeghi K, Borhani Haghighi A. Comparison of medical treatments in cryptogenic stroke patients 131